IP Australia trademark

Alnylam Pharmaceuticals, Inc design mark 1943205

RegisteredIP AustraliaFigurative markClass 5

"Design mark 1943205" is a figurative mark owned by Alnylam Pharmaceuticals, Inc., filed at IP Australia on July 24, 2018. It is registered and covers class 5 (Pharmaceuticals).

View Alnylam Pharmaceuticals, Inc. portfolioGet this data via the API
Official IP Australia record
Alnylam Pharmaceuticals, Inc design mark 1943205 trademark as filed
As filed with IP Australia
Status
Registered
Since December 18, 2018
Filed
July 24, 2018
Registered
July 24, 2018
Expires
July 24, 2028
Application no.
1943205
Registration no.
1943205
Office
IP Australia
IP Australia
Mark type
Figurative mark
1 class
Ownership

Who owns Alnylam Pharmaceuticals, Inc design mark 1943205

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Alnylam Pharmaceuticals, Inc.

ALNY · United States

69 trademarks in the portfolioView company

Representative

Corrs Chambers Westgarth

Corrs Chambers Westgarth

Goods and services

What the mark covers

The products and services Alnylam Pharmaceuticals, Inc design mark 1943205 is filed for, grouped by Nice class.

  • Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection; Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection; pharmaceutical preparations, namely, RNA therapeutics; pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes

History

What has happened so far

Steps recorded by IP Australia, newest first.

  1. IP Right Registered correspondence sent
  2. IP Right Acceptance Published
  3. Amend Status from Awaiting Advertisement
  4. Application Accepted correspondence sent
  5. IP Right Filed Published
  6. Application Status
  7. Application Status
  8. Status change to Filed
  9. Filing an Electronic Application for a TM 1 Class
FAQ

About Alnylam Pharmaceuticals, Inc design mark 1943205

Who owns the trademark "Design mark 1943205"?

IP Australia trademark "Design mark 1943205" (application 1943205) is owned by Alnylam Pharmaceuticals, Inc.

What is the status of "Design mark 1943205"?

Its status at IP Australia is: registered.

When was "Design mark 1943205" registered?

It was registered on July 24, 2018 and is due to expire on July 24, 2028.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Alnylam Pharmaceuticals, Inc design mark 1943205 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019dfc3a-8a24-7368-8835-a9ed1073d141
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019dfc3a-8a24-7368-8835-a9ed1073d141",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "AU",
  "application_number": "1943205",
  "filing_date": "2018-07-24",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Alnylam Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb709-7d9a-70dc-b19d-2c56e8a223b5"
    }
  ]
}